Skip Navigation
Menu
Letters |15 March 1997

Treatment of Behcet Disease with Pentoxifylline

Vedat Hamuryudan, MD; Yilmaz Ozyazgan, MD; Hasan Yazici, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • University of Istanbul, Istanbul, Turkey
×
FULL TEXT
TO THE EDITOR:
We are responsible for the care of almost 3000 patients with Behcet disease and read with great interest the report by Yasui and colleagues on successful treatment of this disease with pentoxifylline [1].
Behcet disease usually runs a course of exacerbations and remissions that gradually abate with time. Exacerbations in the eye cause a sharp decline in visual acuity that almost always improves as the attack subsides. Thus, studies testing treatment for the disease should not allow each patient to be his or her own control (as Yasui and colleagues' study did). Such a method results in a “regression toward the mean” bias. Therefore, if visual acuity is first measured during an attack, as seems to have been done in Yasui and colleagues' study, it will always improve when the attack subsides by itself or with the help of an effective remedy. A much more useful measure to follow is a baseline visual acuity, which reflects the visual acuity when an attack is not occurring.
FULL TEXT
PDF
Not Available
Citations
Citation

Hamuryudan V, Ozyazgan Y, Yazici H. Treatment of Behcet Disease with Pentoxifylline. Ann Intern Med. 1997;126:494. doi: 10.7326/0003-4819-126-6-199703150-00022

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1997;126(6):494.

DOI: 10.7326/0003-4819-126-6-199703150-00022

3 Citations
CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×